Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Weight Loss, Swollen Face Led to Stage 2 Lung Cancer Diagnosis
2
The Current Treatment Landscape in Multiple Myeloma
3
FDA Accepts Besremi Application for Essential Thrombocythemia
4
The Cost of the Unicorn: Why Pancreatic Cancer Survival Isn't a Marathon
5